Has Josue Jimenez Fuentes received payments from drug or device companies?

Yes. Drug and device makers reported $2,423 in general payments to Josue Jimenez Fuentes across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Josue Jimenez Fuentes did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Josue Jimenez Fuentes come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Josue Jimenez Fuentes

Surgery · New York, NYNPI 1235694340

Payments from drug & device makers

$2,423in general payments, 2019–2025

Across 85 payments — averaging $28.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$283
Bridgebio Pharma, Inc.$256
Amgen$201
Novartis$198
Abbott$170
Johnson & Johnson$153
plus $1K from 15 others

What the payments were for

Food & beverage$2,40399%
Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	8	$283
Bridgebio Pharma, Inc.	7	$256
Amgen	8	$201
Novartis	9	$198
Abbott	5	$170
Johnson & Johnson	6	$153
Janssen Scientific Affairs, LLC	1	$143
E.r. Squibb & Sons, L.L.C.	4	$136
Pfizer	6	$122
Merck	5	$120
Boehringer Ingelheim	4	$97
Lexicon Pharmaceuticals, Inc.	4	$93
Alnylam Pharmaceuticals Inc.	3	$72
Endotronix, Inc.	1	$64
Nuwellis, Inc.	2	$61
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	5	$59
Kiniksa Pharmaceuticals International, PLC	2	$50
Abiomed	1	$42
Bayer	2	$42
Cvrx, Inc.	1	$36
Scpharmaceuticals Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,423 in reported general payments places this provider in the 60th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	96	$69,685
JardianceEmpagliflozin	49	$57,539
EntrestoSacubitril/Valsartan	23	$16,156
BrilintaTicagrelor	20	$11,549
Metoprolol Succinate	121	$2,138
Milrinone In 5% DextroseMilrinone Lactate/D5w	17	$1,194
Bumetanide	36	$1,112
Atorvastatin Calcium	73	$698
Amiodarone Hcl	45	$632
ClopidogrelClopidogrel Bisulfate	88	$626
Colchicine	18	$591
Torsemide	43	$580
Pantoprazole Sodium	16	$532
Carvedilol	35	$424
Eplerenone	14	$365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$122	$69,68596 claims
Boehringer IngelheimJardiance	$97	$57,53949 claims
NovartisEntresto	$198	$16,15623 claims
AstraZenecaBrilinta	$283	$11,54920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,596 surgery providers in New York.

Other surgery in New York

Vinod BalachandranNew York$3M
Stephanie GoffNew York$2.7M
Alice WeiNew York$2.3M
Cheguevara AfanehNew York$1.4M
Flavio Malcher Martins de OliveiraNew York$814K
Bonnie LonzeNew York$650K
Yuri NovitskyNew York$548K
Rasa ZarnegarNew York$478K
Tanuja DamaniNew York$459K
Jatin ShahNew York$451K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →